Zobrazeno 1 - 5
of 5
pro vyhledávání: '"HIROKO YONEMITSU"'
Autor:
Naoko Takase, Masatoshi Inden, Shin-ichiro Sekine, Yumi Ishii, Hiroko Yonemitsu, Wakana Iwashita, Hisaka Kurita, Yutaka Taketani, Isao Hozumi
Publikováno v:
Scientific Reports, Vol 7, Iss 1, Pp 1-11 (2017)
Abstract PiT-1 (encoded by SLC20A1) and PiT-2 (encoded by SLC20A2) are type-III sodium-dependent phosphate cotransporters (NaPiTs). Recently, SLC20A2 mutations have been found in patients with idiopathic basal ganglia calcification (IBGC), and were p
Externí odkaz:
https://doaj.org/article/c2fdf9bb6e0a4769bcb73d25890d6623
Autor:
MAYAKO UCHIDA, SHIGERU ISHIDA, ERIKA MOCHIZUKI, NANA OZAWA, HIROKO YONEMITSU, HIDEKI OCHIAI, HANAE NAKAMURA, TAKEHIRO KAWASHIRI, HIROYUKI WATANABE, TOSHIKAZU TSUJI, KIMITAKA SUETSUGU, KOJI KATO, NOBUAKI EGASHIRA, KOICHI AKASHI, ICHIRO IEIRI
Publikováno v:
Cancer Diagnosis & Prognosis; Sep/Oct2024, Vol. 4 Issue 5, p617-622, 6p
Autor:
MAYAKO UCHIDA, SAEKO MURATA, HANAE MORIKAWA, HIROKO YONEMITSU, SHIGERU ISHIDA, KIMITAKA SUETSUGU, TOSHIKAZU TSUJI, HIROYUKI WATANABE, TAKEHIRO KAWASHIRI, KOJI KATO, KEIKO HOSOHATA, TOSHIHIRO MIYAMOTO, NOBUAKI EGASHIRA, TSUTOMU NAKAMURA, KOICHI AKASHI, ICHIRO IEIRI
Publikováno v:
Anticancer research. 42(4)
The occurrence of chemotherapy-related serious adverse events (AEs) is associated with a poor prognosis of hematopoietic malignancies. We have developed a medication guidance sheet (MGS) for monitoring AEs occurring when combining chemotherapy with e
Autor:
MAYAKO UCHIDA, ERIKA MOCHIZUKI, SHIGERU ISHIDA, NANA OZAWA, HIROKO YONEMITSU, HIDEKI OCHIAI, HANAE NAKAMURA, TAKEHIRO KAWASHIRI, KOJI KATO, NOBUAKI EGASHIRA, KOICHI AKASHI, ICHIRO IEIRI
Publikováno v:
In Vivo; Mar/Apr2023, Vol. 37 Issue 2, p924-932, 9p
Autor:
Hiroko Yonemitsu, Yumi Ishii, Shin-ichiro Sekine, Wakana Iwashita, Isao Hozumi, Hisaka Kurita, Yutaka Taketani, Naoko Takase, Masatoshi Inden
Publikováno v:
Scientific Reports
Scientific Reports, Vol 7, Iss 1, Pp 1-11 (2017)
Scientific Reports, Vol 7, Iss 1, Pp 1-11 (2017)
PiT-1 (encoded by SLC20A1) and PiT-2 (encoded by SLC20A2) are type-III sodium-dependent phosphate cotransporters (NaPiTs). Recently, SLC20A2 mutations have been found in patients with idiopathic basal ganglia calcification (IBGC), and were predicted